Finance

Beta
Lists
BFK:SGX
Pharmesis International Ltd.
SGD 0.35
0.00%
(0.00) 1D
Jun 4, 2:31:03 PM GMT+8  ·   SGD
All symbols
SymbolPriceChange% Change
Generating top insights for BFK...
Mkt. cap
11.10M
Avg. vol.
4.54K
Volume
0.00
52-wk high
SGD 0.50
52-wk low
SGD 0.20
EPS
-SGD 0.03
Shares outstanding
31.70M
Mkt. cap
11.10M
Avg. vol.
4.54K
Volume
0.00
52-wk high
SGD 0.50
52-wk low
SGD 0.20
EPS
-SGD 0.03
Shares outstanding
31.70M
News stories
From sources across the web
About Pharmesis International Ltd.
CEO-
Employees-
Founded1996
Headquarters-
SectorPharmaceutical industry
Websitepharmesis.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
13.60M
13.60M
8.28M
8.28M
Cost of goods sold
8.43M
8.43M
5.53M
5.53M
Cost of revenue
8.43M
8.43M
5.53M
5.53M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.74M
5.74M
4.83M
4.83M
Operating expense
5.69M
5.69M
4.88M
4.88M
Total operating expenses
14.12M
14.12M
10.41M
10.41M
Operating income
-519.50K
-519.50K
-2.13M
-2.13M
Other non operating income
-
-
982.50K
982.50K
EBT including unusual items
-686.00K
-686.00K
-1.31M
-1.31M
EBT excluding unusual items
-686.00K
-686.00K
-1.31M
-1.31M
Income tax expense
-
-
153.00K
153.00K
Effective tax rate
-
-
-11.67%
-11.67%
Other operating expenses
-52.00K
-52.00K
52.00K
52.00K
Net income
-686.00K
-686.00K
-1.46M
-1.46M
Net profit margin
-5.04%
-5.04%
-17.70%
-17.70%
Earnings per share
-
-
-
-
Interest and investment income
13.00K
13.00K
-
-
Interest expense
-179.50K
-179.50K
-159.50K
-159.50K
Net interest expenses
-166.50K
-166.50K
-159.50K
-159.50K
Depreciation and amortization charges
-
-
-
-
EBITDA
205.00K
205.00K
-1.71M
-1.71M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer